Cited by 133Genetic Associations and EpidemiologyNutrition, Genetics, and DiseaseGut microbiota and health

Comparative Genome-Wide Association Studies in Mice and Humans for Trimethylamine N -Oxide, a Proatherogenic Metabolite of Choline and l -Carnitine

Open access
Hartiala, Jaana, Bennett, Brian J., Tang, W.H. Wilson, Wang, Zeneng, Stewart, Alexandre F.R., Roberts, Robert, McPherson, Ruth, Lusis, Aldons J. +2 more·2014·Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective—: Elevated levels of plasma trimethylamine N -oxide (TMAO), the product of gut microbiome and hepatic-mediated metabolism of dietary choline and l -carnitine, have recently been identified as a novel risk factor for the development of atherosclerosis in mice and humans. The goal of this study was to identify the genetic factors associated with plasma TMAO levels. Approach and Results—: We used comparative genome-wide association study approaches to discover loci for plasma TMAO levels in mice and humans. A genome-wide association study in the hybrid mouse diversity panel identified a locus for TMAO levels on chromosome 3 ( P =2.37×10 −6 ) that colocalized with a highly significant ( P =1.07×10 −20 ) cis -expression quantitative trait locus for solute carrier family 30 member 7. This zinc transporter could thus represent 1 positional candidate gene responsible for the association signal at this locus in mice. A genome-wide association study for plasma TMAO levels in 1973 humans identified 2 loci with suggestive evidence of association ( P =3.0×10 −7 ) on chromosomes 1q23.3 and 2p12. However, genotyping of the lead variants at these loci in 1892 additional subjects failed to replicate their association with plasma TMAO levels. Conclusions—: The results of these limited observational studies indicate that, at least in humans, genes play a marginal role in determining TMAO levels and that any genetic effects are relatively weak and complex. Variation in diet or the repertoire of gut microbiota may be more important determinants of plasma TMAO levels in mice and humans, which should be investigated in future studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/atvbaha.114.303252

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genetic variation seems to play a minor role in determining circulating levels of TMAO.

    “genetic variation seems to play a minor role in determining the circulating levels of TMAO [15].”
  • A comparative GWAS found a mouse chromosome 3 locus for plasma TMAO (P < 0.001) that co-localized with a strong cis-eQTL for Slc30a7.

    “We used a compara-tive GWAS approach to discover loci for plasma TMAO levels in mice and humans, and identified a locus for TMAO levels on chromosome 3 (P < 0.001) that co-localized with a highly significant (P < 0.001) cis-expression quantitative trait locus for solute carrier family 30 member 7 (Slc30a7) (60).”
  • The zinc transporter Slc30a7 may be a positional candidate for the mouse association signal, but the GWAS associations are weak.

    “Although this zinc transporter might represent a positional candidate gene responsible for the association signal at this locus in mice (60), these are weak associations in GWASs.”
  • FMO3 and TMAO were significantly correlated, and TMAO explained 11% of the variation in atherosclerosis among the inbred mouse strains studied.

    “FMO3 and TMAO were significantly correlated, and TMAO levels accounted for 11% of the variation in atherosclerosis across the inbred strains of mice examined (60).”
  • A human GWAS of plasma TMAO in 1,973 people found two loci with suggestive association (P < 0.001) on chromosomes 1q23.3 and 2p12, but genotyping lead variants in 1,892 more people did not replicate the association.

    “Furthermore, GWASs for plasma TMAO levels in 1,973 humans identified 2 loci with suggestive evidence of association (P < 0.001) on chromosomes 1q23.3 and 2p12; however, genotyping of the lead variants at these loci in 1,892 additional subjects failed to replicate their association with plasma TMAO levels (60).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hartiala, J., Bennett, B. J., Tang, W. H. W., Wang, Z., Stewart, A. F. R., Roberts, R., McPherson, R., Lusis, A. J., Hazen, S. L., & Allayee, H.
Affiliations
University of North Carolina at Chapel Hill (US)
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2014-06
Volume
34
Issue
6
Pages
1307-1313
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2127621744
Cited by
133
References
32
Citations by year
2026: 4 · 2025: 5 · 2024: 9 · 2023: 12 · 2022: 12 · 2021: 12 · 2020: 10 · 2019: 13 · 2018: 8 · 2017: 12 · 2016: 14 · 2015: 16 · 2014: 6
FWCI
10.48
Type
journal article
Language
en
Open access
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Site cant be reached (submittedVersion)
Funders
  • National Institutes of Health (UL1TR000130)
  • Canadian Institutes of Health Research (MOT82810)
  • National Heart, Lung, and Blood Institute (P01 HL-30568, P01HL030568, R00HL102223, R01HL103931, K99HL102223, P20HL113452, P01HL076491, P01HL098055, P01-HL28481, R01HL103866, P01HL028481)
  • National Institute of Environmental Health Sciences (R01ES021801)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
trimethylamine N-oxide, choline metabolism, L-carnitine, gut microbiota, atherosclerosis risk, genetic susceptibility, zinc transporters, Hybrid Mouse Diversity Panel, plasma biomarkers, gene-diet interaction
MeSH terms
Aged, Animals, Carnitine, Choline, Chromosomes, Human, Pair 1, Female, Multigene Family, Humans, Male, Methylamines, Middle Aged, Oxygenases, Polymorphism, Single Nucleotide, Cation Transport Proteins, Mice, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review